Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties.
Secondary progressive multiple sclerosis: a shared therapeutic decision.
Multiple sclerosis: Managing patients in primary care.
JNK inhibitors as anti-inflammatory and neuroprotective agents.
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
Melatonin treatment improves primary progressive multiple sclerosis: a case report.
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
EBV-Associated Cancer and Autoimmunity: Searching for Therapies.
Quality of life among people with multiple sclerosis: Replication of a three-factor prediction model.
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
In vivo immunomodulatory effect of the lectin from edible mushroom Agaricus bisporus.
Brain ageing and disorders of the central nervous system: kynurenines and drug metabolism.
Constraint-induced movement therapy: a method for harnessing neuroplasticity to treat motor disorders.
Smoking as a risk factor for multiple sclerosis.
Acute necrotizing encephalopathy (ANE1): rare autosomal-dominant disorder presenting as acute transverse myelitis.
The re-emergence of antigen-specific tolerance as a potential therapy for MS.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Utilization of the Expanded Disability Status Scale as a distinctive instrument for walking impairment in persons with multiple sclerosis with mild disability.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Pages
« first
‹ previous
…
430
431
432
433
434
435
436
437
438
…
next ›
last »